File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1001/jamaoncol.2020.4564
- Scopus: eid_2-s2.0-85092634324
- PMID: 33001135
- WOS: WOS:000576434100007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial
| Title | Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial |
|---|---|
| Authors | |
| Issue Date | 2020 |
| Publisher | American Medical Association. The Journal's web site is located at http://oncology.jamanetwork.com/journal.aspx |
| Citation | JAMA Oncology, 2020, v. 6 n. 11, p. article no. e204564 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/289380 |
| ISSN | 2021 Impact Factor: 33.006 2020 SCImago Journal Rankings: 8.846 |
| PubMed Central ID | |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yau, TCC | - |
| dc.contributor.author | Kang, YK | - |
| dc.contributor.author | Kim, TY | - |
| dc.contributor.author | El-Khoueiry, AB | - |
| dc.contributor.author | Santoro, A | - |
| dc.contributor.author | Sangro, B | - |
| dc.contributor.author | Melero, I | - |
| dc.contributor.author | Kudo, M | - |
| dc.contributor.author | Hou, MM | - |
| dc.contributor.author | Matilla, A | - |
| dc.contributor.author | Tovoli, F | - |
| dc.contributor.author | Knox, JJ | - |
| dc.contributor.author | He, AR | - |
| dc.contributor.author | El-Rayes, BF | - |
| dc.contributor.author | Acosta-Rivera, M | - |
| dc.contributor.author | Lim, HY | - |
| dc.contributor.author | Neely, J | - |
| dc.contributor.author | Shen, Y | - |
| dc.contributor.author | Wisniewski, T | - |
| dc.contributor.author | Anderson, J | - |
| dc.contributor.author | Hsu, C | - |
| dc.date.accessioned | 2020-10-22T08:11:49Z | - |
| dc.date.available | 2020-10-22T08:11:49Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | JAMA Oncology, 2020, v. 6 n. 11, p. article no. e204564 | - |
| dc.identifier.issn | 2374-2437 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/289380 | - |
| dc.language | eng | - |
| dc.publisher | American Medical Association. The Journal's web site is located at http://oncology.jamanetwork.com/journal.aspx | - |
| dc.relation.ispartof | JAMA Oncology | - |
| dc.title | Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial | - |
| dc.type | Article | - |
| dc.identifier.email | Yau, TCC: tyaucc@hku.hk | - |
| dc.identifier.authority | Yau, TCC=rp01466 | - |
| dc.description.nature | link_to_OA_fulltext | - |
| dc.identifier.doi | 10.1001/jamaoncol.2020.4564 | - |
| dc.identifier.pmid | 33001135 | - |
| dc.identifier.pmcid | PMC7530824 | - |
| dc.identifier.scopus | eid_2-s2.0-85092634324 | - |
| dc.identifier.hkuros | 316115 | - |
| dc.identifier.volume | 6 | - |
| dc.identifier.issue | 11 | - |
| dc.identifier.spage | article no. e204564 | - |
| dc.identifier.epage | article no. e204564 | - |
| dc.identifier.isi | WOS:000576434100007 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 2374-2437 | - |